朱曦
学历：博士
专家类别：讲师
邮箱：zhuxi@kmmu.edu.cn
通讯地址：云南省昆明市呈贡区雨花街道春融西路1168号
邮编：650500
简历
教育经历
(1) 2015-09至2021-06，上海交通大学，生物医学工程，博士
(2) 2011-09至2015-06，中南大学，生物医学工程，学士
工作经历
(1) 2023-05至 今，澳洲5·（中国）集团有限公司,，生物医学工程研究院，讲师
(2) 2021-12至2023-04，澳洲5·（中国）集团有限公司,，康复学院，讲师
研究方向
肿瘤的光学检测及治疗
承担科研项目
（1）云南省科技厅，面上项目，202301AT070272，不完全光动力治疗引起的炎症反应加速残余肿瘤发展的机制研究，2023-06至2026-05，10万元，在研，主持
（2）云南省科技厅-昆医联合专项，面上项目，靶向活化血小板的纳米胶束用于深层转移灶的声动力治疗和光声成像，2023-06至2026-05，10万元，在研，主持
（3）云南省教育厅，2023Y0619，酒精注射用于抑制射频消融术中肿瘤播散的疗效研究，2023-03至2025-02，2万元，在研，主持
研究成果（论文、专利、专著等）
[1]Zhu X*, Suo Y*, Fu Y, et al. In vivo flow cytometry reveals a circadian rhythm of circulating tumor cell.Light: Science & Applications, 2021, 10(1):1-10.
[2] Zhu X*, Wei C*, Zhang Y, et al. Monitoring radiofrequency therapy‐induced tumor cell dissemination by in vivo flow cytometry[J].Cytometry Part A, 2021, 99(6):593-600.
[3] Zhuang B*, Zhu X*, Zhang F, et al. Radiofrequency ablation promote in vivo hepatocellular carcinoma cell releasing into the blood.European Radiology Experimental（接收）
[4] Yu Q*, Yao, Y,* Zhu X*, et al. In Vivo Flow Cytometric Evaluation of Circulating Metastatic Pancreatic Tumor Cells after High-intensity Focused Ultrasound Therapy.Cytometry Part A, 2020, 97(9): 900-908.
[5] Xia J, Ma S, Zhu X, et al. Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches[J]. Science Advances, 2022, 8(6): eabj1262.
[6] Tao L, Liu Q, Zhang F, Fu Y,Zhu X, et al. Microglia modulation with 1070-nm light attenuates Aβ burden and cognitive impairment in Alzheimer’s disease mouse model[J]. Light: Science & Applications, 2021, 10(1): 1-14.
[7] Zhang Y,Zhu X, Chen X, et al. Activated Platelets‐Targeting Micelles with Controlled Drug Release for Effective Treatment of Primary and Metastatic Triple Negative Breast Cancer[J].Advanced Functional Materials, 2019, 29(13): 1806620.
[8] Weng X, Wei D,Zhu X, et al. Real‐time monitoring of single circulating tumor cells with a fluorescently labeled deoxy‐glucose by in vivo flow cytometry[J]. Cytometry Part A, 2021, 99(6): 586- 592.
[9] Suo Y, Xie C,Zhu X, et al. Proportion of circulating tumor cell clusters increases during cancer metastasis[J]. Cytometry Part A, 2017, 91(3): 250-253.
[10] Pang K, Xie C, Yang Z, Suo Y,Zhu X, et al. Monitoring circulating prostate cancer cells by in vivo flow cytometry assesses androgen deprivation therapy on metastasis[J]. Cytometry Part A, 2018, 93(5): 517-524.
